<p>(A) Tumor growth curve and end-point tumor volume at day 15 in A431 xenografts (n = 10) treated with DFMO and diclofenac as individual agent and in combination. @ - significant when DFMO alone compared to vehicle-treated control, # - significant when diclofenac alone compared to vehicle-treated control, $ - significant when DFMO+diclofenac compared to vehicle, & and ? - significant when DFMO+diclofenac compared to single treatment of DFMO and diclofenac respectively. All values are mean±SEM; *, p<0.05, **, p<0.005, ***, p<0.0001. (B) A431 cells (2.5×10<sup>6</sup>) were injected subcutaneously into the right and left flank of nude mice. Representative animal from different groups after 15 days of drug treatment compared to the vehicle-tr...
<p>FEMX-1 xenografts were treated with lexatumumab (L) (10 mg/kg, twice a week, i.v. injection), IgG...
<p>A-D. Effects of combinatorial therapy on DU145 (A), MDA-MB-231 (B), HepG2(C) and RKO (D) xenograf...
<p>(A) Time course of tumor volumes. Treatment with DCA/ADM combination resulted in enhanced efficac...
<p>(A) Clonogenic cell survival assay in DFMO+diclofenac treated A431 cells after 10 days as compare...
<p>(A) The effect of DFMO+diclofenac treatment on levels of epithelial marker, E-cadherin and mesenc...
<p>(A) Tissue sections from A431 xenograft tumors were stained for PCNA or TUNEL. DFMO+diclofenac tr...
<p>(A) Western blot analysis showing expression of ODC and COX-2. The bar diagram represents relativ...
<p>HEY cells (1.5×10<sup>6</sup>) were injected subcutaneously into both flanks of nude mice. A) Mic...
<p>A. The NOD/SCID mice xenograft tumor after treated by DMSO or leflunomide. B. Xenograft tumor vol...
<p>Male 10-week-old C57BL/6J mice were randomly given doxorubicin (15 mg/kg, i.p.) or same volume of...
<p>(A) Proliferation of B16 cells was determined in the presence or absence of diclofenac after 24 h...
<p>Combination therapy was given i. p. in two cycles (d0 - d3 & d21 - d24): On the first day the ani...
<p>Male 10-week-old C57BL/6J mice were randomly given doxorubicin (15 mg/kg, i.p.) or same volume of...
<p>(A) From the outside appearance, the abdomen of tumor group was bulging obviously (b) than the on...
<p>Tumor growth curves for PC-3M-luc, PC-3M-luc-scr, PC-3M-luc -CD44-KD and PC-3M-luc-CD147-KD xenog...
<p>FEMX-1 xenografts were treated with lexatumumab (L) (10 mg/kg, twice a week, i.v. injection), IgG...
<p>A-D. Effects of combinatorial therapy on DU145 (A), MDA-MB-231 (B), HepG2(C) and RKO (D) xenograf...
<p>(A) Time course of tumor volumes. Treatment with DCA/ADM combination resulted in enhanced efficac...
<p>(A) Clonogenic cell survival assay in DFMO+diclofenac treated A431 cells after 10 days as compare...
<p>(A) The effect of DFMO+diclofenac treatment on levels of epithelial marker, E-cadherin and mesenc...
<p>(A) Tissue sections from A431 xenograft tumors were stained for PCNA or TUNEL. DFMO+diclofenac tr...
<p>(A) Western blot analysis showing expression of ODC and COX-2. The bar diagram represents relativ...
<p>HEY cells (1.5×10<sup>6</sup>) were injected subcutaneously into both flanks of nude mice. A) Mic...
<p>A. The NOD/SCID mice xenograft tumor after treated by DMSO or leflunomide. B. Xenograft tumor vol...
<p>Male 10-week-old C57BL/6J mice were randomly given doxorubicin (15 mg/kg, i.p.) or same volume of...
<p>(A) Proliferation of B16 cells was determined in the presence or absence of diclofenac after 24 h...
<p>Combination therapy was given i. p. in two cycles (d0 - d3 & d21 - d24): On the first day the ani...
<p>Male 10-week-old C57BL/6J mice were randomly given doxorubicin (15 mg/kg, i.p.) or same volume of...
<p>(A) From the outside appearance, the abdomen of tumor group was bulging obviously (b) than the on...
<p>Tumor growth curves for PC-3M-luc, PC-3M-luc-scr, PC-3M-luc -CD44-KD and PC-3M-luc-CD147-KD xenog...
<p>FEMX-1 xenografts were treated with lexatumumab (L) (10 mg/kg, twice a week, i.v. injection), IgG...
<p>A-D. Effects of combinatorial therapy on DU145 (A), MDA-MB-231 (B), HepG2(C) and RKO (D) xenograf...
<p>(A) Time course of tumor volumes. Treatment with DCA/ADM combination resulted in enhanced efficac...